Chairman, CEO, and President Thomas E. Polen Jr., leader at Becton Dickinson & Co. (NYSE:BDX), disclosed recent stock transactions involving common shares. Specifically, Mr. Polen reported selling 2,764 shares of the company's common stock on June 1, 2026.
These sales were formally filed with the Securities and Exchange Commission on June 3, 2026, representing a total transaction value of approximately $404,511. The executed sale prices for these shares varied between $145.21 and $147.49 per share, resulting in a weighted average sale price of $146.35.
It is noteworthy that the current market trading price for BDX stands at $145.06, which is positioned close to its 52-week low of $141.82. Despite this valuation point, an analysis provided by InvestingPro suggests that Becton Dickinson may be undervalued at present levels, indicating a Fair Value significantly higher than the current market price, and classifying it among stocks considered highly undervalued.
The report also detailed prior transactions involving Mr. Polen's equity holdings. Before the recent divestiture, Mr. Polen had acquired 20,209 shares of Becton Dickinson common stock through the exercise of stock appreciation rights. These rights carried an exercise price set at $126.16 per share and were structured to vest in four annual installments beginning on November 26, 2017.
The terms governing this award were adjusted following the corporate combination between the Biosciences and Diagnostic Solutions businesses with Waters Corp. This specific acquisition represented a total value of approximately $2,549,567 for Mr. Polen.
Subsequently, following this acquisition, Mr. Polen disposed of 17,445 shares at a price of $146.15 per share, bringing the total proceeds from that disposal to roughly $2,549,586. Such disposals are frequently associated with tax withholding requirements connected to the exercise of equity awards.
Crucially, all reported transactions were executed under the framework of a Rule 10b5-1 plan, which Mr. Polen adopted on March 2, 2026. As a result of these disclosed activities, Mr. Polen's remaining direct ownership stake in Becton Dickinson common stock totals 110,163 shares.
Beyond the executive trading activity, Becton Dickinson reported several significant operational updates. The company released its Q2 2026 earnings report, which demonstrated a performance surpassing analyst projections. Specifically, the adjusted earnings per share (EPS) reached $2.90, exceeding the consensus forecast of $2.78.
On the revenue front, Becton Dickinson reported total revenue of $4.7 billion, slightly above the anticipated figure of $4.67 billion. Furthermore, a subsidiary, Becton Dickinson Euro Finance S.à r.l., successfully completed an underwritten public offering of €600 million in notes due in 2033. These notes carry an interest rate of 3.855% and are fully guaranteed by BD on a senior unsecured basis.
In the realm of product development, Becton Dickinson launched the Elyra Thulium Fiber Laser System. This system is designed for use in urologic stone management and various soft tissue procedures. The availability of the system includes two distinct configurations to accommodate differing operational needs within medical settings.
On a leadership change note, BD announced that Peter Menziuso would assume the role of executive vice president and president of BD Interventional starting June 1. Prior to this appointment, Mr. Menziuso held a senior leadership position at Johnson & Johnson Vision.
Finally, the company was involved in high-level international engagements. Becton Dickinson participated in a roundtable discussion hosted by China’s commerce ministry. It was joined by other major pharmaceutical companies, including Sanofi and Novartis, with the meeting's objective being to engage with foreign pharmaceutical firms operating within the Chinese market.
Key Points of Analysis
- The stock's current trading price ($145.06) remains near its 52-week low ($141.82), suggesting potential valuation sensitivity.
- Executive activity, such as the recent sales by Chairman Polen Jr., could signal internal adjustments or liquidity needs.
- International market access and regulatory environments remain critical, highlighted by participation in a roundtable with China's commerce ministry.